prescription psychotropic drugs; midomafetamine (mdma) preparations for medical purposes; pharmaceutical preparations for managing and treating mental Read More

Classification Information

Class [005]
Prescription psychotropic drugs; midomafetamine (MDMA) preparations for medical purposes; pharmaceutical preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions; psychopharmaceutical preparations for managing and treating diseases, disorders, and conditions related to HPA axis dysregulation, trauma, mood, thought, behavior, and perception; psychedelic therapeutic preparations for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury.

Classification kind code

Class [042]
Medical scientific research and development in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals; Providing medical scientific research information in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals.

Classification kind code

Mark Details

Serial Number

2335846

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 287 on 18^th Jul 2024	Pre-Assessment Letter Sent
Submitted for opposition 30 on 02^th Jul 2024	Filed
Submitted for opposition 1 on 02^th Jul 2024	Created
Submitted for opposition 31 on 02^th Jul 2024	Formalized

LYKOS THERAPEUTICS

Classification Information

Classification kind code

Class [042]Medical scientific research and development in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals; Providing medical scientific research information in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Medical scientific research and development in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals; Providing medical scientific research information in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals.